Brief: Cutia Therapeutics Says Increase In Shareholding By CEO And Executive Director
14/10/2024 02:13
Oct 14 (Reuters) - Cutia Therapeutics 2487.HK :
* INCREASE IN SHAREHOLDING BY CHIEF EXECUTIVE OFFICER AND
EXECUTIVE DIRECTOR
* CEO PURCHASED TOTAL OF 8,000 SHARES ON 9 AND 10 OCTOBER
FOR
HK$102,816
Further company coverage: 2487.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cutia Therapeutics
See all newsBrief: Cutia Therapeutics To Implement Share Repurchase Program From Oct 2 To Dec 31
Brief: Cutia Therapeutics Says Cu-40102 Bags Marketing Approval From Macao Pharmaceutical Administration Bureau
Brief: Cutia Therapeutics Says Nmpa Accepts Biologics License Application For Cu-20101
Brief: Cutia Therapeutics Posts HY Loss Of RMB180.4 MLN
Brief: Cutia Therapeutics Says CU-30101 Obtains Drug Marketing Authorization By NMPA China